|
biomedicina slovenica |
"FILGRASTIM" : 9
-
Skopec Barbara; Škerget Matevž; Žontar Darja; Zadnik Vesna; Zver Samo
Filgrastim-alone versus pegylated filgrastim-alone for autologous peripheral blood stem cells mobilization in newly diagnosed multiple myeloma patients
2017 ►
-
Mlakar Uroš
Indikacije za zdravljenje z eritropoetinom
[Indications for treatment with erythropoietin]
2005 ►
-
Molnar-Novak Helena; Bedernjak-Bajuk Nataša
Agranulocitoza in hepatitis po metimazolu pri bolnici z bazedovko, ki je nastala po terapiji z radiojodom
[Methimazole induced agranulocitosis and hepatitis in patient with Graves disease appeared after radioiodine treatment]
2004 ►
-
Therasse P; Mauriac L; Welnicka-Jaskiewicz M; Bruning P; Čufer T; Bonnefoi H; Tomiak E; Pritchard KI; Hamilton A; Piccart MJ
Final results of a randomized phase III trial comparing cyclophosphamide, epirubicin, and fluorouracil with a dose-intensified epirubicin and cyclophosphamide + filgrastim as neoadjuvant treatment in locally advanced breast cancer: an EORTC-NCIC-SAKK multicenter study
2003 ►
-
Černelč Peter; Andoljšek Dušan; Mlakar Uroš; Pretnar Jože; Modic Mojca; Zupan Irena P; Zver Samo
Effects of molgramostim, filgrastim and lenograstim in the treatment of myelokathexis
2000 ►
-
Lavrič A; Tibaut D; Nemec M; Štalc A
Biological parameters in wistar rats after long-term treatment of filgrastime (BIOFA)
1999 ►
-
Černelč Peter; Andoljšek Dušan; Mlakar Uroš; Modic Mojca; Pretnar Jože; Zver Samo; Zupan Irena
Effects of molgramostim, filgrastim and lenograstim in the treatment of myelokathexis
1999 ►
-
Therasse P; Mauriac L; Welnicka M; Bruning P; Čufer T; Tomiak E; Curran D; Ramirez A; Koopmanschap M; Piccart M
An EORTC-NCIC-SAKK neoadjuvant randomized phase III study comparing CEF (5FU, epirubicin, cyclophosphamide) vs dose intensified EC+G-CSF (filgrastim) in locally advanced breast cancer (LABC): updated results including quality of life
1998 ►
-
Therasse P; Mauriac L; Welincka M; Bruning P; Čufer T; Bonnefoi H; Tomiak E; Hamilton A; Piccart M
Neo-adjuvant dose intensive chemotherapy in locally advanced breast cancer (LABC): an EORTC-NCIC-SAKK randomized phase 3 study comparing FEC (5FU, epirubicin, cyclophosphamide) VS high dose intensity EC + G-CSF (filgrastim)
1998 ►
New search
Comments
Top of page
Institute for Biostatistics and Medical Informatics